• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.单碱基杂合性缺失可作为特定标记，将BRCAx家族性乳腺癌分类为更具同质性的亚型。
Breast J. 2017 Jul;23(4):479-481. doi: 10.1111/tbj.12777. Epub 2017 Jan 24.
2
Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.家族性乳腺癌的表型分析：BRCAx肿瘤与BRCA1、BRCA2携带者及非家族性乳腺癌的比较
Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17.
3
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation.在一个携带种系BRCA2突变的家族中，导管原位癌和三例浸润性乳腺癌中BRCA2基因杂合性缺失。
Breast Cancer Res Treat. 2004 Oct;87(3):273-6. doi: 10.1007/s10549-004-9503-3.
4
[Analyses of LOH and expression in healthy gland, DCIS and invasive breast cancer gland].[健康腺体、导管原位癌及浸润性乳腺癌腺体中杂合性缺失与表达的分析]
Ceska Gynekol. 2009 Apr;74(2):102-5.
5
Comparative analysis of loss of heterozygosity and expression profile in normal tissue, DCIS and invasive breast cancer.正常组织、DCIS 和浸润性乳腺癌中杂合性丢失与表达谱的比较分析。
Clin Transl Oncol. 2011 Sep;13(9):652-5. doi: 10.1007/s12094-011-0710-1.
6
Contralateral Prophylactic Mastectomy Overtreatment: Expectations from Personal Genomics for Tailored Breast Cancer Surgery.对侧预防性乳房切除术的过度治疗：个人基因组学对定制乳腺癌手术的期望。
Ann Surg Oncol. 2010 Mar;17(3):939; author reply 940. doi: 10.1245/s10434-009-0848-z.
7
Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale.对BRCA1和BRCA2基因携带者的导管灌洗样本进行杂合性缺失分析：一则警示故事。
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1396-8. doi: 10.1158/1055-9965.EPI-05-0986.
8
Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.利用激光捕获显微切割的乳腺癌组织进行全基因组杂合性缺失检测：对突变体表型和乳腺癌发病机制的启示
Cancer Res. 2000 Jul 15;60(14):3884-92.
9
Mammographic, US, and MR imaging phenotypes of familial breast cancer.家族性乳腺癌的乳腺X线摄影、超声及磁共振成像表现型
Radiology. 2008 Jan;246(1):58-70. doi: 10.1148/radiol.2461062173.
10
The case against BRCA 1 and 2 testing.反对BRCA 1和2基因检测的理由。
Surgery. 2011 Jun;149(6):731-4. doi: 10.1016/j.surg.2010.11.009.

引用本文的文献

1
Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.14q 染色体杂合性缺失在 C-反应蛋白异常的肾细胞癌患者预后中的作用。
Chin Med J (Engl). 2017 Sep 20;130(18):2176-2182. doi: 10.4103/0366-6999.213962.

本文引用的文献

1
Individualized medicine from prewomb to tomb.从子宫到坟墓的个体化医学。
Cell. 2014 Mar 27;157(1):241-53. doi: 10.1016/j.cell.2014.02.012.
2
MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours.基于 microRNA 的非 BRCA1/2 遗传性乳腺癌肿瘤的分子分类。
Br J Cancer. 2013 Nov 12;109(10):2724-34. doi: 10.1038/bjc.2013.612. Epub 2013 Oct 8.
3
Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?遗传性乳腺癌易感性：终结的开始还是开始的终结？
Am J Pathol. 2013 Oct;183(4):1038-1051. doi: 10.1016/j.ajpath.2013.07.003. Epub 2013 Aug 23.
4
Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease.应用实时 PCR 对疑似骨髓增殖性疾病患者进行基于单核苷酸多态性（SNP）的杂合性缺失（LOH）检测。
PLoS One. 2012;7(7):e38362. doi: 10.1371/journal.pone.0038362. Epub 2012 Jul 2.
5
A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients.通过对遗传相关患者的 aCGH 分析定义非 BRCA1/2 遗传性乳腺癌亚组。
Breast Cancer Res Treat. 2011 Nov;130(2):425-36. doi: 10.1007/s10549-011-1357-x. Epub 2011 Feb 1.
6
Transcriptional characteristics of familial non-BRCA1/BRCA2 breast tumors.家族性非 BRCA1/BRCA2 乳腺癌肿瘤的转录特征。
Int J Cancer. 2011 Jun 1;128(11):2635-44. doi: 10.1002/ijc.25603. Epub 2010 Oct 8.
7
Pathology of hereditary breast cancer.遗传性乳腺癌的病理学。
Mod Pathol. 2010 May;23 Suppl 2:S46-51. doi: 10.1038/modpathol.2010.37.
8
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.在非BRCA1/BRCA2家族性乳腺肿瘤中GATA3频繁发生体细胞突变，但在BRCA1、BRCA2或散发性乳腺肿瘤中并非如此。
Breast Cancer Res Treat. 2010 Jan;119(2):491-6. doi: 10.1007/s10549-008-0269-x. Epub 2009 Feb 3.
9
Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.通过比较基因组杂交分析BRCAx乳腺癌中的基因异质性。
Cancer Genet Cytogenet. 2008 Apr 15;182(2):75-83. doi: 10.1016/j.cancergencyto.2008.01.002.
10
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.在与不同免疫组化亚型相关的家族性乳腺癌中发现了不同的基因组畸变模式。
Oncogene. 2008 May 15;27(22):3165-75. doi: 10.1038/sj.onc.1210975. Epub 2007 Dec 10.

Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.

作者信息

Downs Bradley, Xiao Fengxia, Kim Yeong C, Chen Pei Xian, Huang Dali, Fleissner Elizabeth A, Cowan Kenneth, Wang San Ming

机构信息

Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.

Department of Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

出版信息

Breast J. 2017 Jul;23(4):479-481. doi: 10.1111/tbj.12777. Epub 2017 Jan 24.

DOI:10.1111/tbj.12777
PMID:28117528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5505784/
Abstract
摘要